Follow the entities shaping the evidence.

… −1.26, leptin −1.01, respectively) and at admission after TBI (leptin −1.51, visfatin −1.44, adiponectin −1.51, and resistin −1.29, a…

…e were no significant differences in myopia progression between atropine and placebo treated eyes, there were trends towards less myopic…

…is a preventive strategy that significantly reduces the risk of HIV infection, although it does not protect against other sexually …

…gimens for rNSCLC were durvalumab, nivolumab, pembrolizumab and toripalimab. The estimated hazard ratio of immunotherapy regimens for the a…

…nd lymph node (9%). In metastatic disease, 40 patients received gemcitabine-nabpaclitaxel as first-line treatment. Seventy-two percent of patients receiv…

…entified, of which 149 (7.5%) involved herbal or food products: apixaban 42 (28.2%), dabigatran 42 (28.2%), edoxaban 23 (15.4%), rivarox…

…Background and Importance Colorectal cancer is the third most diagnosed cancer and the second leading cause…

… constipation, nausea, and weight loss.Conclusion and Relevance Gepants used in the treatment of migraine appear to reduce migraine day…

…vention less, but still 14/34 (41.2%), patients reported having oxycodone tablets left.Conclusion and Relevance The multifaceted interven…

…re recorded. At the end of follow-up, two patients continued on risankizumab monotherapy, while three maintained the combination therapy.Con…

…en antibiotic consumption and the evolution of MDRB rates in an orthopaedic institute over a 3-year period.Material and Methods A retrospective study…

…ge and a predominant use of narrow-spectrum antibiotics such as ceftriaxone. The optimisation of antimicrobial use has not negatively affec…